TD Asset Management »

Monte Rosa Therapeutics shares owned by TD Asset Management

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.1M 193k 5.65
2023-09-30 $925k 193k 4.79
2023-06-30 $799k 117k 6.85
2023-03-31 $1.1M 141k 7.79
2022-12-31 $1.1M 141k 7.61
2022-09-30 $1.1M 141k 7.84
2022-06-30 $1.4M 141k 9.67
2022-03-31 $2.0M 141k 14.02
2021-12-31 $2.7M 132k 20.42
2021-09-30 $864k 39k 22.29
2021-06-30 $950k 39k 24.51